These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10636261)

  • 1. Endothelium: a new target for cardiovascular therapeutics.
    Deedwania PC
    J Am Coll Cardiol; 2000 Jan; 35(1):67-70. PubMed ID: 10636261
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study).
    Anderson TJ; Elstein E; Haber H; Charbonneau F
    J Am Coll Cardiol; 2000 Jan; 35(1):60-6. PubMed ID: 10636260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study].
    Eleuteri E
    Ital Heart J Suppl; 2000 Jun; 1(6):830-1. PubMed ID: 11204017
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Osswald H; Mühlbauer B
    J Hypertens Suppl; 1995 Aug; 13(2):S21-8. PubMed ID: 8576784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The coronary circulation, renin-angiotensin system and ACE inhibition].
    Campa PP
    Cardiologia; 1995 Sep; 40(9):635-41. PubMed ID: 8542615
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular Benefits of Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Black Hypertensive Patients.
    Brook RD; Kaciroti N; Jamerson T; Jamerson KA
    Hypertension; 2021 Sep; 78(4):1150-1152. PubMed ID: 34420368
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.
    Erinc K; Yamani MH; Starling RC; Crowe T; Hobbs R; Bott-Silverman C; Rincon G; Young JB; Feng J; Cook DJ; Smedira N; Tuzcu EM
    J Heart Lung Transplant; 2005 Aug; 24(8):1033-8. PubMed ID: 16102438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients.
    Engholm M; Mulvany MJ; Eftekhari A; Mathiassen ON; Buus NH; Christensen KL
    J Hum Hypertens; 2016 Nov; 30(11):690-696. PubMed ID: 26961172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endothelial dysfunction and angiotensin-converting enzyme inhibitors in coronary disease].
    Mélon P
    Rev Med Liege; 1998 Jun; 53(6):353-4. PubMed ID: 9713215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia.
    van Gilst WH; Tio RA; van Wijngaarden J; de Graeff PA; Wesseling H
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S134-9. PubMed ID: 1381790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
    Zeiher AM; Schächinger V
    Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists: an antihypertensive alternative].
    Bruun NE; Pedersen OL
    Ugeskr Laeger; 1990 Feb; 152(7):453-6. PubMed ID: 2408216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?
    Smith I; Jackson I
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):687-90. PubMed ID: 20805745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peace-study. Coronary heart disease: additive therapy with ACE-inhibitors?].
    Böhm M
    Internist (Berl); 2005 May; 46(5):592-4. PubMed ID: 15834542
    [No Abstract]   [Full Text] [Related]  

  • 18. The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.
    Bainbridge AD; Macfadyen RJ; Stark S; Lees KR; Reid JL
    Br J Clin Pharmacol; 1993 Oct; 36(4):323-30. PubMed ID: 12959310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?].
    Joost HG
    Dtsch Med Wochenschr; 2003 Feb; 128(8):398. PubMed ID: 12594628
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.